Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

A Pediatric Intra-Axial Malignant SMARCB1-Deficient Desmoplastic Tumor Arising in Meningioangiomatosis.

Rossi S, Brenca M, Zanatta L, Trincia E, Guerriero A, Pizzato C, Fiorindi A, Viscardi E, Giangaspero F, Maestro R, Dei Tos AP, Giannini C.

J Neuropathol Exp Neurol. 2018 Oct 1;77(10):883-889. doi: 10.1093/jnen/nly075.

PMID:
30169623
2.

Development of a performance model for virtual reality tumor resections.

Sawaya R, Alsideiri G, Bugdadi A, Winkler-Schwartz A, Azarnoush H, Bajunaid K, Sabbagh AJ, Del Maestro R.

J Neurosurg. 2018 Aug 3:1-9. doi: 10.3171/2018.2.JNS172327. [Epub ahead of print]

PMID:
30074456
3.

Is Virtual Reality Surgical Performance Influenced by Force Feedback Device Utilized?

Bugdadi A, Sawaya R, Bajunaid K, Olwi D, Winkler-Schwartz A, Ledwos N, Marwa I, Alsideiri G, Sabbagh AJ, Alotaibi FE, Al-Zhrani G, Maestro RD.

J Surg Educ. 2018 Jul 30. pii: S1931-7204(18)30207-1. doi: 10.1016/j.jsurg.2018.06.012. [Epub ahead of print]

PMID:
30072262
4.

From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo.

Altinoz MA, Nalbantoglu J, Ozpinar A, Emin Ozcan M, Del Maestro RF, Elmaci I.

Clin Neurol Neurosurg. 2018 Oct;173:20-30. doi: 10.1016/j.clineuro.2018.07.012. Epub 2018 Jul 19.

PMID:
30055402
5.

Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma.

Urbini M, Indio V, Astolfi A, Tarantino G, Renne SL, Pilotti S, Dei Tos AP, Maestro R, Collini P, Nannini M, Saponara M, Murrone L, Dagrada GP, Colombo C, Gronchi A, Pession A, Casali PG, Stacchiotti S, Pantaleo MA.

Int J Mol Sci. 2018 Jun 23;19(7). pii: E1855. doi: 10.3390/ijms19071855.

6.

A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness.

di Gennaro A, Damiano V, Brisotto G, Armellin M, Perin T, Zucchetto A, Guardascione M, Spaink HP, Doglioni C, Snaar-Jagalska BE, Santarosa M, Maestro R.

Cell Death Differ. 2018 Apr 17. doi: 10.1038/s41418-018-0103-x. [Epub ahead of print]

PMID:
29666469
7.

Virtual Reality Tumor Resection: The Force Pyramid Approach.

Sawaya R, Bugdadi A, Azarnoush H, Winkler-Schwartz A, Alotaibi FE, Bajunaid K, AlZhrani GA, Alsideiri G, Sabbagh AJ, Del Maestro RF.

Oper Neurosurg (Hagerstown). 2018 Jun 1;14(6):686-696. doi: 10.1093/ons/opx189.

PMID:
28962033
8.

Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue.

Urbini M, Astolfi A, Indio V, Tarantino G, Serravalle S, Saponara M, Nannini M, Gronchi A, Fiore M, Maestro R, Brenca M, Dei Tos AP, Dagrada GP, Negri T, Pilotti S, Casali PG, Biasco G, Pession A, Stacchiotti S, Pantaleo MA.

Oncotarget. 2017 May 17;8(36):60036-60045. doi: 10.18632/oncotarget.17958. eCollection 2017 Sep 1.

9.

Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs.

Rossi S, Gasparotto D, Cacciatore M, Sbaraglia M, Mondello A, Polano M, Mandolesi A, Gronchi A, Reuss DE, von Deimling A, Maestro R, Dei Tos AP.

Mod Pathol. 2018 Jan;31(1):160-168. doi: 10.1038/modpathol.2017.105. Epub 2017 Sep 1.

PMID:
28862263
10.

Automaticity of Force Application During Simulated Brain Tumor Resection: Testing the Fitts and Posner Model.

Bugdadi A, Sawaya R, Olwi D, Al-Zhrani G, Azarnoush H, Sabbagh AJ, Alsideiri G, Bajunaid K, Alotaibi FE, Winkler-Schwartz A, Del Maestro R.

J Surg Educ. 2018 Jan - Feb;75(1):104-115. doi: 10.1016/j.jsurg.2017.06.018. Epub 2017 Jul 3.

PMID:
28684100
11.

A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer.

Viel A, Bruselles A, Meccia E, Fornasarig M, Quaia M, Canzonieri V, Policicchio E, Urso ED, Agostini M, Genuardi M, Lucci-Cordisco E, Venesio T, Martayan A, Diodoro MG, Sanchez-Mete L, Stigliano V, Mazzei F, Grasso F, Giuliani A, Baiocchi M, Maestro R, Giannini G, Tartaglia M, Alexandrov LB, Bignami M.

EBioMedicine. 2017 Jun;20:39-49. doi: 10.1016/j.ebiom.2017.04.022. Epub 2017 Apr 13.

12.

The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.

Di Giorgio E, Franforte E, Cefalù S, Rossi S, Dei Tos AP, Brenca M, Polano M, Maestro R, Paluvai H, Picco R, Brancolini C.

PLoS Genet. 2017 Apr 18;13(4):e1006752. doi: 10.1371/journal.pgen.1006752. eCollection 2017 Apr.

13.

HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.

Urbini M, Astolfi A, Pantaleo MA, Serravalle S, Dei Tos AP, Picci P, Indio V, Sbaraglia M, Benini S, Righi A, Gambarotti M, Gronchi A, Colombo C, Dagrada GP, Pilotti S, Maestro R, Polano M, Saponara M, Tarantino G, Pession A, Biasco G, Casali PG, Stacchiotti S.

Genes Chromosomes Cancer. 2017 Jul;56(7):582-586. doi: 10.1002/gcc.22462. Epub 2017 May 4.

PMID:
28383167
14.

Learning brain aneurysm microsurgical skills in a human placenta model: predictive validity.

de Oliveira MMR, Ferrarez CE, Ramos TM, Malheiros JA, Nicolato A, Machado CJ, Ferreira MT, de Oliveira FB, de Sousa CFPM, Costa PHV, Gusmao S, Lanzino G, Maestro RD.

J Neurosurg. 2018 Mar;128(3):846-852. doi: 10.3171/2016.10.JNS162083. Epub 2017 Mar 24.

PMID:
28338438
15.

Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.

Damiano V, Brisotto G, Borgna S, di Gennaro A, Armellin M, Perin T, Guardascione M, Maestro R, Santarosa M.

Genes Chromosomes Cancer. 2017 Feb;56(2):147-158. doi: 10.1002/gcc.22422. Epub 2016 Nov 1.

PMID:
27717206
16.

Low-dose radiotherapy in diffuse large B-cell lymphoma.

Furlan C, Canzonieri V, Spina M, Michieli M, Ermacora A, Maestro R, Piccinin S, Bomben R, Dal Bo M, Trovo M, Gattei V, Tirelli U, Franchin G, Bulian P.

Hematol Oncol. 2017 Dec;35(4):472-479. doi: 10.1002/hon.2368. Epub 2016 Oct 25.

PMID:
27781290
17.

Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework.

Bozzi F, Brich S, Dagrada GP, Negri T, Conca E, Cortelazzi B, Belfiore A, Perrone F, Gualeni AV, Gloghini A, Cabras A, Brenca M, Maestro R, Zaffaroni N, Casali P, Bertulli R, Deraco M, Pilotti S.

Oncotarget. 2016 Nov 15;7(46):75503-75517. doi: 10.18632/oncotarget.12262.

18.

The force pyramid: a spatial analysis of force application during virtual reality brain tumor resection.

Azarnoush H, Siar S, Sawaya R, Zhrani GA, Winkler-Schwartz A, Alotaibi FE, Bugdadi A, Bajunaid K, Marwa I, Sabbagh AJ, Del Maestro RF.

J Neurosurg. 2017 Jul;127(1):171-181. doi: 10.3171/2016.7.JNS16322. Epub 2016 Sep 30.

PMID:
27689458
19.

Bimanual Psychomotor Performance in Neurosurgical Resident Applicants Assessed Using NeuroTouch, a Virtual Reality Simulator.

Winkler-Schwartz A, Bajunaid K, Mullah MAS, Marwa I, Alotaibi FE, Fares J, Baggiani M, Azarnoush H, Zharni GA, Christie S, Sabbagh AJ, Werthner P, Del Maestro RF.

J Surg Educ. 2016 Nov - Dec;73(6):942-953. doi: 10.1016/j.jsurg.2016.04.013. Epub 2016 Jul 7.

PMID:
27395397
20.

Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.

Gasparotto D, Rossi S, Polano M, Tamborini E, Lorenzetto E, Sbaraglia M, Mondello A, Massani M, Lamon S, Bracci R, Mandolesi A, Frate E, Stanzial F, Agaj J, Mazzoleni G, Pilotti S, Gronchi A, Dei Tos AP, Maestro R.

Clin Cancer Res. 2017 Jan 1;23(1):273-282. doi: 10.1158/1078-0432.CCR-16-0152. Epub 2016 Jul 7.

21.

Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours.

Spagnuolo RD, Brich S, Bozzi F, Conca E, Castelli C, Tazzari M, Maestro R, Brenca M, Gualeni AV, Gloghini A, Stacchiotti S, Pierotti MA, Pilotti S, Negri T.

Oncotarget. 2016 Jul 19;7(29):45015-45026. doi: 10.18632/oncotarget.7523.

22.

Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.

Stacchiotti S, Astolfi A, Gronchi A, Fontana A, Pantaleo MA, Negri T, Brenca M, Tazzari M, Urbini M, Indio V, Colombo C, Radaelli S, Brich S, Dei Tos AP, Casali PG, Castelli C, Dagrada GP, Pilotti S, Maestro R.

Mol Cancer Res. 2016 Sep;14(9):820-9. doi: 10.1158/1541-7786.MCR-16-0068. Epub 2016 Jun 2.

23.

Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.

Rossi S, Sbaraglia M, Dell'Orto MC, Gasparotto D, Cacciatore M, Boscato E, Carraro V, Toffolatti L, Gallina G, Niero M, Pilozzi E, Mandolesi A, Sessa F, Sonzogni A, Mancini C, Mazzoleni G, Romeo S, Maestro R, Dei Tos AP.

Oncotarget. 2016 May 24;7(21):30109-18. doi: 10.18632/oncotarget.8768.

24.

Impact of acute stress on psychomotor bimanual performance during a simulated tumor resection task.

Bajunaid K, Mullah MA, Winkler-Schwartz A, Alotaibi FE, Fares J, Baggiani M, Azarnoush H, Christie S, Al-Zhrani G, Marwa I, Sabbagh AJ, Werthner P, Del Maestro RF.

J Neurosurg. 2017 Jan;126(1):71-80. doi: 10.3171/2015.5.JNS15558. Epub 2016 Mar 11.

PMID:
26967787
25.

Face, Content, and Construct Validity of Brain Tumor Microsurgery Simulation Using a Human Placenta Model.

Oliveira MM, Araujo AB, Nicolato A, Prosdocimi A, Godinho JV, Valle ALM, Santos M, Reis AB, Ferreira MT, Sabbagh A, Gusmao S, Del Maestro R.

Oper Neurosurg (Hagerstown). 2016 Mar 1;12(1):61-67. doi: 10.1227/NEU.0000000000001030.

PMID:
29506248
26.

Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study.

Hafsi S, Candido S, Maestro R, Falzone L, Soua Z, Bonavida B, Spandidos DA, Libra M.

Oncol Lett. 2016 Feb;11(2):1021-1025. Epub 2015 Dec 14.

27.

Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.

Cini G, Mezzavilla M, Della Puppa L, Cupelli E, Fornasin A, D'Elia AV, Dolcetti R, Damante G, Bertok S, Miolo G, Maestro R, de Paoli P, Amoroso A, Viel A.

BMC Med Genet. 2016 Feb 6;17:11. doi: 10.1186/s12881-016-0274-6.

28.

Morphologic shift associated with aberrant cytokeratin expression in a GIST patient after tyrosine kinase inhibitors therapy. A case report with a brief review of the literature.

Canzonieri V, Gasparotto D, Alessandrini L, Miolo G, Torrisi E, Perin T, De Paoli P, Maestro R, Buonadonna A.

Pathol Res Pract. 2016 Jan;212(1):63-7. doi: 10.1016/j.prp.2015.11.004. Epub 2015 Nov 10. Review.

PMID:
26616113
29.

Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.

Brenca M, Rossi S, Polano M, Gasparotto D, Zanatta L, Racanelli D, Valori L, Lamon S, Dei Tos AP, Maestro R.

J Pathol. 2016 Mar;238(4):543-9. doi: 10.1002/path.4677. Epub 2016 Jan 25.

PMID:
26606880
30.

Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives.

Brenca M, Maestro R.

Expert Rev Anticancer Ther. 2015;15(12):1473-88. doi: 10.1586/14737140.2015.1108192. Epub 2015 Nov 4. Review.

PMID:
26536249
31.

Face, content, and construct validity of human placenta as a haptic training tool in neurointerventional surgery.

Ribeiro de Oliveira MM, Nicolato A, Santos M, Godinho JV, Brito R, Alvarenga A, Martins AL, Prosdocimi A, Trivelato FP, Sabbagh AJ, Reis AB, Maestro RD.

J Neurosurg. 2016 May;124(5):1238-44. doi: 10.3171/2015.1.JNS141583. Epub 2015 Oct 9.

PMID:
26452122
32.

An improved sequencing-based strategy to estimate locus-specific DNA methylation.

Brisotto G, di Gennaro A, Damiano V, Armellin M, Perin T, Maestro R, Santarosa M.

BMC Cancer. 2015 Sep 21;15:639. doi: 10.1186/s12885-015-1646-6.

33.

Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).

Stacchiotti S, Pantaleo MA, Negri T, Astolfi A, Tazzari M, Dagrada GP, Urbini M, Indio V, Maestro R, Gronchi A, Fiore M, Dei Tos AP, Conca E, Palassini E, Vincenzi B, Grosso F, Pilotti S, Castelli C, Casali PG.

Clin Cancer Res. 2016 Feb 15;22(4):837-46. doi: 10.1158/1078-0432.CCR-15-1243. Epub 2015 Aug 10.

34.

Effect of process variables on the sulfate reduction process in bioreactors treating metal-containing wastewaters: factorial design and response surface analyses.

Villa-Gomez DK, Pakshirajan K, Maestro R, Mushi S, Lens PN.

Biodegradation. 2015 Jul;26(4):299-311. doi: 10.1007/s10532-015-9735-4. Epub 2015 Jun 14.

PMID:
26071684
35.

KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.

Rossi S, Gasparotto D, Miceli R, Toffolatti L, Gallina G, Scaramel E, Marzotto A, Boscato E, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Mariani L, Amore P, Gronchi A, Casali PG, Maestro R, Dei Tos AP.

Am J Surg Pathol. 2015 Jul;39(7):922-30. doi: 10.1097/PAS.0000000000000418.

PMID:
25970686
36.

Neurosurgical Assessment of Metrics Including Judgment and Dexterity Using the Virtual Reality Simulator NeuroTouch (NAJD Metrics).

Alotaibi FE, AlZhrani GA, Sabbagh AJ, Azarnoush H, Winkler-Schwartz A, Del Maestro RF.

Surg Innov. 2015 Dec;22(6):636-42. doi: 10.1177/1553350615579729. Epub 2015 Apr 7.

PMID:
25851146
37.

Operator experience determines performance in a simulated computer-based brain tumor resection task.

Holloway T, Lorsch ZS, Chary MA, Sobotka S, Moore MM, Costa AB, Del Maestro RF, Bederson J.

Int J Comput Assist Radiol Surg. 2015 Nov;10(11):1853-62. doi: 10.1007/s11548-015-1160-y. Epub 2015 Mar 26.

PMID:
25805306
38.

Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.

Cini G, Carnevali I, Quaia M, Chiaravalli AM, Sala P, Giacomini E, Maestro R, Tibiletti MG, Viel A.

Carcinogenesis. 2015 Apr;36(4):452-8. doi: 10.1093/carcin/bgv015. Epub 2015 Mar 5.

PMID:
25742745
39.

Proficiency performance benchmarks for removal of simulated brain tumors using a virtual reality simulator NeuroTouch.

AlZhrani G, Alotaibi F, Azarnoush H, Winkler-Schwartz A, Sabbagh A, Bajunaid K, Lajoie SP, Del Maestro RF.

J Surg Educ. 2015 Jul-Aug;72(4):685-96. doi: 10.1016/j.jsurg.2014.12.014. Epub 2015 Feb 14.

PMID:
25687956
40.

miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression.

Hemmesi K, Squadrito ML, Mestdagh P, Conti V, Cominelli M, Piras IS, Sergi LS, Piccinin S, Maestro R, Poliani PL, Speleman F, De Palma M, Galli R.

Stem Cells. 2015 May;33(5):1377-89. doi: 10.1002/stem.1958.

41.

Assessing bimanual performance in brain tumor resection with NeuroTouch, a virtual reality simulator.

Alotaibi FE, AlZhrani GA, Mullah MA, Sabbagh AJ, Azarnoush H, Winkler-Schwartz A, Del Maestro RF.

Neurosurgery. 2015 Mar;11 Suppl 2:89-98; discussion 98. doi: 10.1227/NEU.0000000000000631.

PMID:
25599201
42.

Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor.

Gasparotto D, Rossi S, Campagna D, Scavina P, Tiziano FD, Marzotto A, Toffolatti L, Vitelli CE, Amini M, Dei Tos AP, Maestro R.

J Clin Oncol. 2016 Apr 10;34(11):e99-e103. doi: 10.1200/JCO.2012.44.7300. Epub 2014 Dec 29. No abstract available.

PMID:
25547508
43.

In silico prediction of physical protein interactions and characterization of interactome orphans.

Kotlyar M, Pastrello C, Pivetta F, Lo Sardo A, Cumbaa C, Li H, Naranian T, Niu Y, Ding Z, Vafaee F, Broackes-Carter F, Petschnigg J, Mills GB, Jurisicova A, Stagljar I, Maestro R, Jurisica I.

Nat Methods. 2015 Jan;12(1):79-84. doi: 10.1038/nmeth.3178. Epub 2014 Nov 17.

PMID:
25402006
44.

Development of the McGill simulator for endoscopic sinus surgery: a new high-fidelity virtual reality simulator for endoscopic sinus surgery.

Varshney R, Frenkiel S, Nguyen LH, Young M, Del Maestro R, Zeitouni A, Tewfik MA; National Research Council Canada.

Am J Rhinol Allergy. 2014 Jul-Aug;28(4):330-4. doi: 10.2500/ajra.2014.28.4046.

PMID:
25197920
45.

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Davis NM, Sokolosky M, Stadelman K, Abrams SL, Libra M, Candido S, Nicoletti F, Polesel J, Maestro R, D'Assoro A, Drobot L, Rakus D, Gizak A, Laidler P, Dulińska-Litewka J, Basecke J, Mijatovic S, Maksimovic-Ivanic D, Montalto G, Cervello M, Fitzgerald TL, Demidenko Z, Martelli AM, Cocco L, Steelman LS, McCubrey JA.

Oncotarget. 2014 Jul 15;5(13):4603-50. Review.

46.

Neurosurgical virtual reality simulation metrics to assess psychomotor skills during brain tumor resection.

Azarnoush H, Alzhrani G, Winkler-Schwartz A, Alotaibi F, Gelinas-Phaneuf N, Pazos V, Choudhury N, Fares J, DiRaddo R, Del Maestro RF.

Int J Comput Assist Radiol Surg. 2015 May;10(5):603-18. doi: 10.1007/s11548-014-1091-z. Epub 2014 Jun 27.

PMID:
24965186
47.

GSK-3 as potential target for therapeutic intervention in cancer.

McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, Cocco L, Martelli AM, Cervello M.

Oncotarget. 2014 May 30;5(10):2881-911. Review.

48.

Identification of targets of Twist1 transcription factor in thyroid cancer cells.

Di Maro G, Orlandella FM, Bencivenga TC, Salerno P, Ugolini C, Basolo F, Maestro R, Salvatore G.

J Clin Endocrinol Metab. 2014 Sep;99(9):E1617-26. doi: 10.1210/jc.2013-3799. Epub 2014 May 21.

PMID:
24848707
49.

YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.

Lorenzetto E, Brenca M, Boeri M, Verri C, Piccinin E, Gasparini P, Facchinetti F, Rossi S, Salvatore G, Massimino M, Sozzi G, Maestro R, Modena P.

Oncotarget. 2014 May 15;5(9):2608-21.

50.

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.

Candido S, Maestro R, Polesel J, Catania A, Maira F, Signorelli SS, McCubrey JA, Libra M.

Oncotarget. 2014 Mar 30;5(6):1576-94.

Supplemental Content

Loading ...
Support Center